Anterix (ATEX) Financials

$26.95 -0.31 (-1.14%)

Closing price 04:00 PM Eastern

Extended Trading

$26.95 0.00 (0.00%)

As of 04:27 PM Eastern

Annual Income Statements for Anterix

This table shows Anterix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	3/31/2024	3/31/2023	3/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-9.13	-16	-38
Consolidated Net Income / (Loss)	-9.13	-16	-38
Net Income / (Loss) Continuing Operations	-9.13	-16	-38
Total Pre-Tax Income	-7.52	-15	-37
Total Operating Income	-10	-16	-37
Total Gross Profit	4.19	1.92	1.08
Total Revenue	4.19	1.92	1.08
Operating Revenue	4.19	1.92	1.08
Total Cost of Revenue	0.00	0.00	0.01
Total Operating Expenses	14	18	38
Selling, General & Admin Expense	44	45	40
Marketing Expense	5.69	5.73	4.46
Research & Development Expense	5.70	4.44	3.59
Depreciation Expense	0.84	1.42	1.45
Other Special Charges / (Income)	-42	-38	-11
Total Other Income / (Expense), net	2.61	1.41	0.31
Interest & Investment Income	2.37	1.14	0.06
Other Income / (Expense), net	0.23	0.27	0.26
Income Tax Expense	1.61	1.26	0.98
Basic Earnings per Share	($0.49)	($0.87)	($2.07)
Weighted Average Basic Shares Outstanding	18.77M	18.84M	18.14M
Diluted Earnings per Share	($0.49)	($0.87)	($2.07)
Weighted Average Diluted Shares Outstanding	18.77M	18.84M	18.14M
Weighted Average Basic & Diluted Shares Outstanding	18.57M	19.04M	18.93M

This table shows Anterix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2024	12/31/2024	9/30/2023	6/30/2024	3/31/2023	12/31/2022	9/30/2022	6/30/2022	3/31/2022	12/31/2021
Net Income / (Loss) Attributable to Common Shareholders	-9.41	7.71	2.07	-16	16	-8.02	-11	-13	-11	-13
Consolidated Net Income / (Loss)	-9.41	7.71	2.07	-16	16	-8.02	-11	-13	-11	-13
Net Income / (Loss) Continuing Operations	-9.41	7.71	2.07	-16	16	-8.02	-11	-13	-11	-13
Total Pre-Tax Income	-9.54	7.48	2.72	-14	16	-7.81	-10	-13	-11	-12
Total Operating Income	-11	7.03	2.26	-15	16	-8.40	-11	-13	-11	-12
Total Gross Profit	1.26	1.57	1.05	1.53	0.61	0.58	0.40	0.34	0.34	0.38
Total Revenue	1.26	1.57	1.05	1.53	0.61	0.58	0.40	0.34	0.34	0.39
Operating Revenue	1.26	1.57	1.05	1.53	0.61	0.58	0.40	0.34	0.34	0.39
Total Operating Expenses	12	-5.47	-1.21	17	-15	8.98	11	13	11	13
Selling, General & Admin Expense	9.59	9.20	12	13	10	12	11	11	9.75	10
Marketing Expense	1.73	1.31	1.31	1.85	1.95	1.39	1.16	1.24	1.15	1.26
Research & Development Expense	2.24	1.12	1.15	1.75	1.43	0.94	0.98	1.10	0.77	0.89
Depreciation Expense	0.19	0.14	0.21	0.18	0.31	0.37	0.37	0.36	0.45	0.32
Other Special Charges / (Income)	-1.98	-21	-16	-	-29	-5.80	-2.89	-0.65	-0.98	0.06
Total Other Income / (Expense), net	0.97	0.44	0.46	0.71	0.50	0.59	0.23	0.08	0.06	0.07
Interest & Investment Income	0.93	0.43	0.40	0.69	0.47	0.41	0.24	0.02	0.00	0.01
Other Income / (Expense), net	0.04	0.01	0.06	0.02	0.03	0.19	-0.01	0.06	0.06	0.06
Income Tax Expense	-0.13	-0.23	0.65	1.22	0.64	0.21	0.22	0.20	0.27	0.41
Basic Earnings per Share	($0.51)	$0.41	$0.11	($0.84)	$0.82	($0.42)	($0.56)	($0.71)	($0.60)	($0.69)
Weighted Average Basic Shares Outstanding	18.77M	18.61M	18.92M	18.49M	18.84M	18.93M	18.95M	18.62M	18.14M	18.31M
Diluted Earnings per Share	($0.51)	$0.41	$0.11	($0.84)	$0.82	($0.42)	($0.56)	($0.71)	($0.60)	($0.69)
Weighted Average Diluted Shares Outstanding	18.77M	18.78M	19.11M	18.49M	18.84M	18.93M	18.95M	18.62M	18.14M	18.31M
Weighted Average Basic & Diluted Shares Outstanding	18.57M	18.59M	18.62M	18.59M	19.04M	18.87M	18.96M	18.94M	18.93M	18.31M

This table details how cash moves in and out of Anterix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	3/31/2024	3/31/2023	3/31/2022
Net Change in Cash & Equivalents	25	-62	-12
Net Cash From Operating Activities	42	-27	18
Net Cash From Continuing Operating Activities	42	-27	18
Net Income / (Loss) Continuing Operations	-9.13	-16	-38
Consolidated Net Income / (Loss)	-9.13	-16	-38
Depreciation Expense	0.84	1.42	1.45
Non-Cash Adjustments To Reconcile Net Income	-28	-20	2.16
Changes in Operating Assets and Liabilities, net	78	8.12	52
Net Cash From Investing Activities	8.09	-27	-27
Net Cash From Continuing Investing Activities	8.09	-27	-27
Purchase of Property, Plant & Equipment	-0.31	-2.13	-1.05
Acquisitions	-17	-25	-26
Divestitures	25	0.00	-
Net Cash From Financing Activities	-25	-8.06	-2.42
Net Cash From Continuing Financing Activities	-25	-8.06	-2.42
Repurchase of Common Equity	-25	-8.22	-15
Other Financing Activities, net	-0.46	0.16	13

This table details how cash moves in and out of Anterix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022	3/31/2022	12/31/2021
Net Change in Cash & Equivalents	-1.43	21	14	-14	-14	-13	-16	-19	-22	27
Net Cash From Operating Activities	6.14	34	4.57	-8.21	-8.57	-0.73	-8.12	-9.83	-9.12	40
Net Cash From Continuing Operating Activities	6.14	34	4.57	-8.21	-8.57	-0.73	-8.12	-9.83	-9.12	40
Net Income / (Loss) Continuing Operations	-9.41	0.33	15	-2.12	16	-8.02	-11	-13	-11	-13
Consolidated Net Income / (Loss)	-9.41	0.33	15	-2.12	16	-8.02	-11	-13	-11	-13
Depreciation Expense	0.19	0.20	0.28	0.25	0.31	0.37	0.37	0.36	0.45	0.32
Non-Cash Adjustments To Reconcile Net Income	1.40	-9.95	-23	-7.19	-24	-1.29	1.93	3.18	3.31	3.28
Changes in Operating Assets and Liabilities, net	14	43	12	0.85	-0.15	8.21	0.47	-0.42	-1.03	48
Net Cash From Investing Activities	-2.26	-4.54	20	-5.20	-6.52	-8.24	-5.72	-6.66	-11	-4.21
Net Cash From Continuing Investing Activities	-2.26	-4.54	20	-5.20	-6.52	-8.24	-5.72	-6.66	-11	-4.21
Purchase of Property, Plant & Equipment	-0.04	-0.06	-0.21	-0.03	-0.58	-0.40	-1.14	-0.01	-0.80	-0.04
Acquisitions	-2.22	-4.73	-4.68	-5.17	-5.94	-7.84	-4.58	-6.65	-10	-4.16
Net Cash From Financing Activities	-5.30	-8.09	-11	-0.75	0.76	-3.64	-2.51	-2.68	-1.89	-8.53
Net Cash From Continuing Financing Activities	-5.30	-8.09	-11	-0.75	0.76	-3.64	-2.51	-2.68	-1.89	-8.53
Repurchase of Common Equity	-5.97	-7.97	-8.71	0.00	-	-3.50	-2.00	-2.73	-2.97	-12
Other Financing Activities, net	0.67	-0.12	-1.97	-0.75	0.76	-0.14	-0.51	0.05	1.08	3.47

This table presents Anterix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	3/31/2024	3/31/2023	3/31/2022
Total Assets	325	279	278
Total Current Assets	73	59	116
Cash & Equivalents	61	43	106
Prepaid Expenses	3.91	2.44	10
Other Current Assets	8.52	14	-
Plant, Property, & Equipment, net	2.06	3.61	2.95
Total Noncurrent Assets	250	215	159
Intangible Assets	217	202	151
Other Noncurrent Operating Assets	33	13	8.16
Total Liabilities & Shareholders' Equity	325	279	278
Total Liabilities	164	99	92
Total Current Liabilities	18	32	9.64
Short-Term Debt	1.00	20	0.00
Accounts Payable	8.63	6.62	6.65
Accrued Expenses	0.00	-	-
Current Deferred Revenue	6.47	2.77	1.48
Other Current Liabilities	1.85	2.26	1.51
Total Noncurrent Liabilities	146	67	82
Noncurrent Deferred Revenue	116	58	53
Noncurrent Deferred & Payable Income Tax Liabilities	6.28	5.44	4.19
Other Noncurrent Operating Liabilities	24	3.44	25
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	161	180	186
Total Preferred & Common Equity	161	180	186
Preferred Stock	0.00	0.00	0.00
Total Common Equity	161	180	186
Common Stock	533	518	500
Retained Earnings	-372	-338	-314

This table presents Anterix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	12/31/2022	9/30/2022	6/30/2022	12/31/2021
Total Assets	327	317	321	258	256	264	288
Total Current Assets	40	57	66	72	82	98	135
Cash & Equivalents	29	43	52	58	70	86	128
Prepaid Expenses	3.14	1.58	2.97	15	12	12	7.27
Other Current Assets	8.35	12	11	-	-	-	-
Plant, Property, & Equipment, net	1.58	1.73	1.84	3.34	3.32	2.59	2.64
Total Noncurrent Assets	285	259	254	182	171	163	150
Intangible Assets	246	222	220	170	159	155	144
Other Noncurrent Operating Assets	39	37	34	12	11	8.60	5.93
Total Liabilities & Shareholders' Equity	327	317	321	258	256	264	288
Total Liabilities	182	178	172	99	90	90	92
Total Current Liabilities	24	16	17	31	30	8.97	9.87
Short-Term Debt	5.40	1.00	1.00	20	20	-	-
Accounts Payable	9.01	7.09	7.75	6.68	5.51	5.21	6.94
Accrued Expenses	2.29	-	-	-	-	-	-
Current Deferred Revenue	5.96	5.92	5.97	2.66	2.51	2.19	1.48
Other Current Liabilities	1.75	1.81	1.81	1.75	1.63	1.57	1.45
Total Noncurrent Liabilities	158	162	156	67	60	81	83
Noncurrent Deferred Revenue	120	121	115	59	51	52	54
Noncurrent Deferred & Payable Income Tax Liabilities	6.74	7.67	7.34	4.81	4.60	4.39	3.92
Other Noncurrent Operating Liabilities	31	34	34	3.73	3.92	24	25
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	145	139	149	159	166	175	196
Total Preferred & Common Equity	145	139	149	159	166	175	196
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	145	139	149	159	166	175	196
Common Stock	544	542	539	513	508	504	495
Retained Earnings	-399	-402	-390	-354	-342	-330	-300

This table displays calculated financial ratios and metrics derived from Anterix's official financial filings.

Metric	2024	2023	2022
Period end date	3/31/2024	3/31/2023	3/31/2022
Growth Metrics	-	-	-
Revenue Growth	118.40%	77.03%	17.70%
EBITDA Growth	38.78%	57.96%	30.91%
EBIT Growth	38.94%	55.74%	32.73%
NOPAT Growth	38.51%	55.33%	32.77%
Net Income Growth	44.06%	56.51%	31.07%
EPS Growth	43.68%	57.97%	33.87%
Operating Cash Flow Growth	254.10%	-252.12%	279.87%
Free Cash Flow Firm Growth	155.09%	-662.84%	55.37%
Invested Capital Growth	-35.32%	94.44%	-15.05%
Revenue Q/Q Growth	18.42%	16.59%	54.42%
EBITDA Q/Q Growth	-152.43%	64.04%	2.02%
EBIT Q/Q Growth	-160.72%	62.03%	1.04%
NOPAT Q/Q Growth	-150.74%	61.67%	1.10%
Net Income Q/Q Growth	-157.68%	61.94%	-0.22%
EPS Q/Q Growth	-158.33%	62.01%	0.96%
Operating Cash Flow Q/Q Growth	53.94%	1.98%	-52.54%
Free Cash Flow Firm Q/Q Growth	97.26%	-4.46%	-168.74%
Invested Capital Q/Q Growth	-8.79%	28.82%	18.88%
Profitability Metrics	-	-	-
Gross Margin	100.00%	100.00%	99.54%
EBITDA Margin	-215.82%	-769.93%	-3,241.88%
Operating Margin	-241.52%	-857.79%	-3,399.26%
EBIT Margin	-235.96%	-843.93%	-3,375.65%
Profit (Net Income) Margin	-217.80%	-850.29%	-3,461.16%
Tax Burden Percent	121.46%	108.38%	102.69%
Interest Burden Percent	75.99%	92.96%	99.85%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-5.49%	-9.70%	-29.37%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.53%	-2.24%	-18.86%
Return on Net Nonoperating Assets (RNNOA)	0.13%	0.79%	10.55%
Return on Equity (ROE)	-5.36%	-8.91%	-18.82%
Cash Return on Invested Capital (CROIC)	37.41%	-73.85%	-13.09%
Operating Return on Assets (OROA)	-3.28%	-5.82%	-13.78%
Return on Assets (ROA)	-3.03%	-5.86%	-14.13%
Return on Common Equity (ROCE)	-5.36%	-8.91%	-18.82%
Return on Equity Simple (ROE_SIMPLE)	-5.67%	-9.08%	-20.14%
Net Operating Profit after Tax (NOPAT)	-7.09	-12	-26
NOPAT Margin	-169.06%	-600.45%	-2,379.48%
Net Nonoperating Expense Percent (NNEP)	-4.95%	-7.46%	-10.51%
Cost of Revenue to Revenue	0.00%	0.00%	0.46%
SG&A Expenses to Revenue	1,059.96%	2,354.19%	3,646.22%
R&D to Revenue	135.93%	231.32%	331.46%
Operating Expenses to Revenue	341.52%	957.79%	3,498.80%
Earnings before Interest and Taxes (EBIT)	-9.89	-16	-37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-9.05	-15	-35
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	3.87	3.47	5.71
Price to Tangible Book Value (P/TBV)	0.00	0.00	30.29
Price to Revenue (P/Rev)	148.52	324.87	981.47
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	5.55	3.83	11.88
Enterprise Value to Revenue (EV/Rev)	134.31	312.92	884.03
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	13.40	0.00	53.50
Enterprise Value to Free Cash Flow (EV/FCFF)	11.65	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.01	0.11	0.00
Long-Term Debt to Equity	0.00	0.00	0.00
Financial Leverage	-0.24	-0.35	-0.56
Leverage Ratio	1.77	1.52	1.33
Compound Leverage Factor	1.35	1.41	1.33
Debt to Total Capital	0.62%	10.12%	0.00%
Short-Term Debt to Total Capital	0.62%	10.12%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.38%	89.88%	100.00%
Debt to EBITDA	-0.11	-1.37	0.00
Net Debt to EBITDA	6.59	1.55	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00
Debt to NOPAT	-0.14	-1.76	0.00
Net Debt to NOPAT	8.41	1.99	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00
Altman Z-Score	0.79	2.02	5.41
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	4.07	1.86	12.01
Quick Ratio	3.37	1.35	10.96
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	48	-88	-11
Operating Cash Flow to CapEx	13,678.50%	-1,281.75%	1,701.14%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.01	0.01	0.00
Accounts Receivable Turnover	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	1.48	0.59	0.33
Accounts Payable Turnover	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	476,471.00
Cash Conversion Cycle (CCC)	0.00	0.00	-476,471.00
Capital & Investment Metrics	-	-	-
Invested Capital	101	157	81
Invested Capital Turnover	0.03	0.02	0.01
Increase / (Decrease) in Invested Capital	-55	76	-14
Enterprise Value (EV)	563	600	958
Market Capitalization	622	623	1,064
Book Value per Share	$8.70	$9.53	$10.14
Tangible Book Value per Share	($3.01)	($1.18)	$1.91
Total Capital	162	200	186
Total Debt	1.00	20	0.00
Total Long-Term Debt	0.00	0.00	0.00
Net Debt	-60	-23	-106
Capital Expenditures (CapEx)	0.31	2.13	1.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-4.52	4.63	0.51
Debt-free Net Working Capital (DFNWC)	56	48	106
Net Working Capital (NWC)	55	28	106
Net Nonoperating Expense (NNE)	2.04	4.79	12
Net Nonoperating Obligations (NNO)	-60	-23	-106
Total Depreciation and Amortization (D&A)	0.84	1.42	1.45
Debt-free, Cash-free Net Working Capital to Revenue	-107.80%	241.06%	47.14%
Debt-free Net Working Capital to Revenue	1,337.63%	2,491.30%	9,791.05%
Net Working Capital to Revenue	1,313.77%	1,436.11%	9,791.05%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.49)	($0.87)	($2.07)
Adjusted Weighted Average Basic Shares Outstanding	18.77M	18.84M	18.14M
Adjusted Diluted Earnings per Share	($0.49)	($0.87)	($2.07)
Adjusted Weighted Average Diluted Shares Outstanding	18.77M	18.84M	18.14M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	18.57M	19.04M	18.93M
Normalized Net Operating Profit after Tax (NOPAT)	-37	-38	-34
Normalized NOPAT Margin	-876.31%	-2,000.78%	-3,096.40%
Pre Tax Income Margin	-179.31%	-784.52%	-3,370.48%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-270.33%	-50.40%	-39.88%

This table displays calculated financial ratios and metrics derived from Anterix's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2024	12/31/2024	9/30/2024	6/30/2024	3/31/2023	12/31/2022	9/30/2022	6/30/2022	3/31/2022	12/31/2021
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	107.24%	170.93%	289.70%	355.22%	81.49%	50.13%	118.68%	84.07%	812.77%	-18.43%
EBITDA Growth	-164.14%	192.28%	-24.80%	-19.37%	255.69%	33.07%	-898.06%	-10.32%	6.58%	-7.22%
EBIT Growth	-166.63%	185.68%	-23.03%	-15.24%	246.20%	33.24%	-548.75%	-9.44%	3.47%	-2.99%
NOPAT Growth	-148.86%	223.28%	-23.17%	-14.84%	299.10%	32.09%	-524.49%	-9.28%	3.65%	-2.58%
Net Income Growth	-160.55%	196.13%	-19.95%	-17.64%	241.07%	36.92%	-498.93%	-9.88%	-0.75%	-5.18%
EPS Growth	-162.20%	197.62%	-23.21%	-18.31%	236.67%	39.13%	-460.00%	-4.41%	3.23%	0.00%
Operating Cash Flow Growth	171.61%	4,720.88%	156.36%	75.99%	6.03%	-101.84%	-177.09%	-1.75%	-185.19%	768.51%
Free Cash Flow Firm Growth	178.60%	112.83%	189.59%	-503.23%	-1,007.86%	-275.11%	-343.31%	104.59%	41.61%	341.48%
Invested Capital Growth	-35.32%	-0.34%	-16.60%	11.32%	94.44%	79.43%	3.39%	-13.91%	-15.05%	-38.68%
Revenue Q/Q Growth	-0.87%	0.97%	155.10%	150.82%	5.19%	45.23%	18.81%	0.00%	-12.99%	111.54%
EBITDA Q/Q Growth	-957.76%	156.32%	-414.57%	-192.48%	304.21%	23.83%	17.02%	-20.62%	12.22%	-1,035.95%
EBIT Q/Q Growth	-1,146.70%	153.63%	-378.50%	-195.46%	291.13%	22.99%	17.99%	-21.11%	12.73%	-648.45%
NOPAT Q/Q Growth	-3,956.73%	178.90%	-362.49%	-169.79%	355.96%	21.16%	18.45%	-20.99%	12.69%	-624.96%
Net Income Q/Q Growth	-2,969.21%	160.39%	-502.74%	-199.88%	293.79%	24.65%	19.35%	-19.78%	13.35%	-615.53%
EPS Q/Q Growth	-2,650.00%	159.42%	-527.27%	-202.44%	295.24%	25.00%	21.13%	-18.33%	13.04%	-590.00%
Operating Cash Flow Q/Q Growth	-81.75%	635.46%	293.73%	72.46%	-1,077.75%	91.03%	17.45%	-7.76%	-123.02%	1,452.99%
Free Cash Flow Firm Q/Q Growth	348.10%	-24.05%	184.43%	66.49%	-2.25%	-430.35%	-321.93%	-24.56%	-80.28%	1,442.66%
Invested Capital Q/Q Growth	-8.79%	25.18%	-1.16%	-37.48%	28.82%	4.77%	31.93%	9.20%	18.88%	-39.63%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	98.70%
EBITDA Margin	-815.56%	462.32%	-828.76%	-971.61%	2,635.20%	-1,357.44%	-2,587.94%	-3,705.37%	-3,071.94%	-3,044.94%
Operating Margin	-834.21%	449.04%	-846.55%	-984.39%	2,578.13%	-1,453.98%	-2,678.39%	-3,902.09%	-3,225.07%	-3,214.29%
EBIT Margin	-830.71%	449.68%	-846.55%	-983.34%	2,583.72%	-1,421.97%	-2,681.41%	-3,884.48%	-3,207.46%	-3,197.92%
Profit (Net Income) Margin	-746.90%	492.34%	-823.08%	-1,017.97%	2,556.25%	-1,387.54%	-2,674.12%	-3,939.10%	-3,288.66%	-3,302.60%
Tax Burden Percent	98.64%	103.13%	101.83%	108.54%	96.06%	102.69%	102.06%	101.54%	102.54%	103.35%
Interest Burden Percent	91.15%	106.16%	95.48%	95.37%	102.99%	95.02%	97.71%	99.87%	99.99%	99.93%
Effective Tax Rate	0.00%	-3.13%	0.00%	0.00%	3.94%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-18.95%	14.61%	-18.60%	-16.23%	40.02%	-17.67%	-23.83%	-35.49%	-27.87%	-17.70%
ROIC Less NNEP Spread (ROIC-NNEP)	-13.97%	13.10%	-10.83%	-8.91%	39.26%	-15.08%	-19.61%	-31.30%	-24.77%	-14.26%
Return on Net Nonoperating Assets (RNNOA)	3.38%	-2.62%	3.26%	3.78%	-13.79%	7.02%	7.79%	15.77%	13.86%	8.13%
Return on Equity (ROE)	-15.57%	11.99%	-15.33%	-12.45%	26.23%	-10.65%	-16.04%	-19.72%	-14.00%	-9.57%
Cash Return on Invested Capital (CROIC)	37.41%	17.93%	12.39%	-15.40%	-73.85%	-88.56%	-32.06%	-12.96%	-13.09%	18.74%
Operating Return on Assets (OROA)	-11.54%	5.90%	-9.88%	-7.36%	17.82%	-8.58%	-15.20%	-18.75%	-13.09%	-8.48%
Return on Assets (ROA)	-10.37%	6.46%	-9.61%	-7.62%	17.63%	-8.37%	-15.16%	-19.02%	-13.42%	-8.76%
Return on Common Equity (ROCE)	-15.57%	11.99%	-15.33%	-12.45%	26.23%	-10.65%	-16.04%	-19.72%	-14.00%	-9.57%
Return on Equity Simple (ROE_SIMPLE)	0.00%	16.03%	-5.29%	-3.52%	0.00%	-26.96%	-28.64%	-22.17%	0.00%	-19.14%
Net Operating Profit after Tax (NOPAT)	-7.36	7.25	-9.19	-11	15	-5.88	-7.46	-9.15	-7.56	-8.66
NOPAT Margin	-583.94%	463.10%	-592.59%	-689.08%	2,476.62%	-1,017.79%	-1,874.87%	-2,731.46%	-2,257.55%	-2,250.00%
Net Nonoperating Expense Percent (NNEP)	-4.98%	1.51%	-7.77%	-7.31%	0.75%	-2.59%	-4.22%	-4.18%	-3.10%	-3.43%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.30%
SG&A Expenses to Revenue	761.35%	587.68%	734.82%	842.69%	1,695.07%	2,090.83%	2,871.11%	3,390.75%	2,910.75%	2,654.29%
R&D to Revenue	178.02%	71.52%	114.51%	114.75%	234.70%	161.94%	246.23%	327.16%	228.96%	231.95%
Operating Expenses to Revenue	934.21%	-349.04%	946.55%	1,090.49%	-2,478.13%	1,553.98%	2,778.39%	4,002.09%	3,325.07%	3,312.99%
Earnings before Interest and Taxes (EBIT)	-10	7.04	-13	-15	16	-8.22	-11	-13	-11	-12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-10	7.24	-13	-15	16	-7.85	-10	-12	-10	-12
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.87	3.95	5.04	4.94	3.47	3.84	4.07	4.46	5.71	5.52
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	102.22	39.53	30.29	21.09
Price to Revenue (P/Rev)	148.52	148.94	209.35	335.38	324.87	370.55	465.72	628.63	981.47	1,537.34
Price to Earnings (P/E)	0.00	24.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	4.06%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	5.55	4.51	6.79	6.98	3.83	4.70	5.39	7.85	11.88	14.02
Enterprise Value to Revenue (EV/Rev)	134.31	142.83	196.76	312.25	312.92	347.92	431.40	558.74	884.03	1,355.34
Enterprise Value to EBITDA (EV/EBITDA)	0.00	23.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	24.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	25.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	13.40	20.07	0.00	0.00	0.00	0.00	49.92	38.95	53.50	25.21
Enterprise Value to Free Cash Flow (EV/FCFF)	11.65	25.12	49.85	0.00	0.00	0.00	0.00	0.00	0.00	56.89
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.01	0.04	0.01	0.01	0.11	0.13	0.12	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.24	-0.20	-0.30	-0.42	-0.35	-0.47	-0.40	-0.50	-0.56	-0.57
Leverage Ratio	1.77	1.92	1.88	1.81	1.52	1.54	1.35	1.34	1.33	1.28
Compound Leverage Factor	1.61	2.04	1.79	1.73	1.57	1.46	1.32	1.33	1.33	1.27
Debt to Total Capital	0.62%	3.59%	0.71%	0.67%	10.12%	11.30%	10.87%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.62%	3.59%	0.71%	0.67%	10.12%	11.30%	10.87%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.38%	96.41%	99.29%	99.33%	89.88%	88.71%	89.13%	100.00%	100.00%	100.00%
Debt to EBITDA	-0.11	0.23	-0.13	-0.21	-1.37	-0.49	-0.45	0.00	0.00	0.00
Net Debt to EBITDA	6.59	-1.00	5.57	10.82	1.55	0.91	1.10	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-0.14	0.25	-0.16	-0.23	-1.76	-0.67	-0.62	0.00	0.00	0.00
Net Debt to NOPAT	8.41	-1.09	6.92	11.63	1.99	1.24	1.52	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.79	0.31	0.61	0.90	2.40	1.88	2.76	3.69	5.71	5.93
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.07	1.65	3.59	3.98	1.86	2.31	2.74	10.96	12.01	13.68
Quick Ratio	3.37	1.18	2.73	3.13	1.35	1.84	2.34	9.64	10.96	12.94
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	48	7.67	10	-20	-61	-60	-11	5.08	6.73	34
Operating Cash Flow to CapEx	15,350.00%	61,163.64%	2,157.55%	0.00%	-1,470.67%	-182.91%	-712.55%	-163,866.67%	-1,139.08%	92,160.47%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	1.48	1.56	1.33	0.99	0.59	0.55	0.46	0.41	0.33	0.22
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	376,643.50	378,943.00	476,471.00	526,038.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	-376,643.50	-378,943.00	-476,471.00	-526,038.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	101	121	97	98	157	122	116	88	81	68
Invested Capital Turnover	0.03	0.03	0.03	0.02	0.02	0.02	0.01	0.01	0.01	0.01
Increase / (Decrease) in Invested Capital	-55	-0.42	-19	9.97	76	54	3.81	-14	-14	-43
Enterprise Value (EV)	563	548	658	684	600	573	627	691	958	951
Market Capitalization	622	571	700	735	623	610	677	778	1,064	1,079
Book Value per Share	$8.70	$7.77	$7.48	$8.01	$9.53	$8.39	$8.77	$9.22	$10.14	$10.65
Tangible Book Value per Share	($3.01)	($5.45)	($4.45)	($3.82)	($1.18)	($0.56)	$0.35	$1.04	$1.91	$2.79
Total Capital	162	150	140	150	200	179	186	175	186	196
Total Debt	1.00	5.40	1.00	1.00	20	20	20	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-60	-23	-42	-51	-23	-37	-50	-86	-106	-128
Capital Expenditures (CapEx)	0.04	0.06	0.21	0.00	0.58	0.40	1.14	0.01	0.80	0.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-4.52	-7.52	-1.16	-1.55	4.63	3.88	2.06	2.91	0.51	-2.60
Debt-free Net Working Capital (DFNWC)	56	21	42	50	48	61	72	89	106	125
Net Working Capital (NWC)	55	16	41	49	28	41	52	89	106	125
Net Nonoperating Expense (NNE)	2.05	-0.46	3.58	5.02	-0.48	2.14	3.18	4.05	3.45	4.05
Net Nonoperating Obligations (NNO)	-60	-23	-42	-51	-23	-37	-50	-86	-106	-128
Total Depreciation and Amortization (D&A)	0.19	0.20	0.28	0.18	0.31	0.37	0.37	0.60	0.45	0.59
Debt-free, Cash-free Net Working Capital to Revenue	-107.80%	-196.19%	-34.74%	-70.80%	241.06%	235.42%	141.84%	235.00%	47.14%	-370.80%
Debt-free Net Working Capital to Revenue	1,337.63%	554.90%	1,254.62%	2,288.46%	2,491.30%	3,729.40%	4,967.31%	7,224.17%	9,791.05%	17,829.20%
Net Working Capital to Revenue	1,313.77%	414.14%	1,224.72%	2,242.84%	1,436.11%	2,499.21%	3,573.71%	7,224.17%	9,791.05%	17,829.20%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.51)	$0.41	($0.69)	($0.84)	$0.82	($0.42)	($0.56)	($0.71)	($0.60)	($0.69)
Adjusted Weighted Average Basic Shares Outstanding	18.77M	18.61M	18.59M	18.49M	18.84M	18.93M	18.95M	18.62M	18.14M	18.37M
Adjusted Diluted Earnings per Share	($0.51)	$0.41	($0.69)	($0.84)	$0.82	($0.42)	($0.56)	($0.71)	($0.60)	($0.69)
Adjusted Weighted Average Diluted Shares Outstanding	18.77M	18.78M	18.59M	18.49M	18.84M	18.93M	18.95M	18.62M	18.14M	18.37M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	($0.69)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	18.57M	18.59M	18.62M	18.59M	19.04M	18.87M	18.96M	18.94M	18.93M	18.31M
Normalized Net Operating Profit after Tax (NOPAT)	-8.75	-7.15	-9.19	-11	-13	-9.94	-9.48	-9.60	-8.25	-8.62
Normalized NOPAT Margin	-694.17%	-456.30%	-592.59%	-689.08%	-2,114.96%	-1,719.84%	-2,382.29%	-2,866.45%	-2,462.96%	-2,239.64%
Pre Tax Income Margin	-757.22%	477.39%	-808.25%	-937.84%	2,661.02%	-1,351.21%	-2,620.10%	-3,879.40%	-3,207.16%	-3,195.58%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-270.33%	80.61%	-193.33%	-104.94%	-50.40%	-26.10%	-41.38%	-45.70%	-39.88%	-32.04%

Frequently Asked Questions About Anterix's Financials

When does Anterix's fiscal year end?

According to the most recent income statement we have on file, Anterix's financial year ends in March. Their financial year 2024 ended on March 31, 2024.

How has Anterix's net income changed over the last 2 years?

Anterix's net income appears to be on a downward trend, with a most recent value of -$9.13 million in 2024, falling from -$37.52 million in 2022. The previous period was -$16.32 million in 2023. Find out what analysts predict for Anterix in the coming months.

What is Anterix's operating income?

Anterix's total operating income in 2024 was -$10.12 million, based on the following breakdown:

Total Gross Profit: $4.19 million
Total Operating Expenses: $14.31 million

How has Anterix revenue changed over the last 2 years?

Over the last 2 years, Anterix's total revenue changed from $1.08 million in 2022 to $4.19 million in 2024, a change of 286.6%.

How much debt does Anterix have?

Anterix's total liabilities were at $163.86 million at the end of 2024, a 65.9% increase from 2023, and a 78.6% increase since 2022.

How much cash does Anterix have?

In the past 2 years, Anterix's cash and equivalents has ranged from $43.18 million in 2023 to $105.62 million in 2022, and is currently $60.58 million as of their latest financial filing in 2024.

How has Anterix's book value per share changed over the last 2 years?

Over the last 2 years, Anterix's book value per share changed from 10.14 in 2022 to 8.70 in 2024, a change of -14.2%.

Related Companies

This page (NASDAQ:ATEX) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Anterix (ATEX) Financials

Frequently Asked Questions About Anterix's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Anterix (ATEX) Financials

Annual Income Statements for Anterix

Quarterly Income Statements for Anterix

Annual Cash Flow Statements for Anterix

Quarterly Cash Flow Statements for Anterix

Annual Balance Sheets for Anterix

Quarterly Balance Sheets for Anterix

Annual Metrics And Ratios for Anterix

Quarterly Metrics And Ratios for Anterix

Frequently Asked Questions About Anterix's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools